Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
701.11
764.02
861.48
788.13
849.74
900.78
1,359.02
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
701.11
764.02
861.48
788.13
849.74
900.78
1,359.02
Raw Material Cost
237.31
271.61
246.73
267.18
252.36
250.79
365.78
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.03
2.99
3.05
22.30
0.00
0.00
0.00
Selling and Distribution Expenses
302.40
324.68
397.45
371.18
394.98
426.80
613.93
Other Expenses
10.20
10.01
11.73
13.31
11.16
12.65
19.56
Total Expenditure (Excl Depreciation)
644.78
699.37
764.52
793.76
758.93
804.12
1,175.30
Operating Profit (PBDIT) excl Other Income
56.3
64.7
97
-5.6000000000000005
90.8
96.7
183.70000000000002
Other Income
28.97
25.97
9.87
17.47
33.60
56.30
15.42
Operating Profit (PBDIT)
75.39
129.29
156.15
33.86
164.52
187.51
225.91
Interest
3.03
2.99
3.05
22.30
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
463.80
492.42
614.75
520.96
597.38
649.99
993.24
Depreciation
0.00
49.32
49.32
54.07
54.07
48.30
48.30
Profit Before Tax
72.36
76.99
103.79
-42.51
110.45
139.21
177.60
Tax
13.37
13.84
18.23
-59.43
17.76
17.48
28.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
57.27
58.96
83.41
34.72
91.72
117.38
148.04
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
57.27
58.96
83.41
34.72
91.72
117.38
148.04
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.72
4.20
2.14
-17.78
0.97
4.35
1.52
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
58.99
63.16
85.55
16.94
92.69
121.73
149.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,714.22
4,656.95
4,597.99
4,514.58
5,150.15
5,148.52
5,326.72
Earnings per share (EPS)
0.1
0.1
0.15
0.06
0.16
0.2
0.25
Diluted Earnings per share
0.1
0.1
0.15
0.06
0.16
0.2
0.25
Operating Profit Margin (Excl OI)
6.62%
7.07%
11.26%
-4.78%
9.04%
9.2%
11.93%
Gross Profit Margin
10.32%
16.53%
17.77%
1.47%
19.36%
20.82%
16.62%
PAT Margin
8.17%
7.72%
9.68%
4.4%
10.79%
13.03%
10.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is -17.49% vs -9.88% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -36.35% vs 20.55% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -64.55% vs 13.24% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Jiangsu Kanion Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
701.11
0
701.11
Other Operating Income
0.00
0.00
0.00
Total Operating income
701.11
0
701.11
Raw Material Cost
237.31
0
237.31
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.03
0
3.03
Selling and Distribution Expenses
302.40
0
302.40
Other Expenses
10.20
0.00
10.20
Total Expenditure (Excl Depreciation)
644.78
0
644.78
Operating Profit (PBDIT) excl Other Income
56.33
0.00
56.33
Other Income
28.97
0
28.97
Operating Profit (PBDIT)
75.39
0
75.39
Interest
3.03
0
3.03
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
463.80
0
463.80
Depreciation
0.00
0
0.00
Profit Before Tax
72.36
0
72.36
Tax
13.37
0
13.37
Provisions and contingencies
0
0
0.00
Profit After Tax
57.27
0
57.27
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
57.27
0
57.27
Share in Profit of Associates
0
0
0.00
Minority Interest
1.72
0
1.72
Other related items
0.00
0.00
0.00
Consolidated Net Profit
58.99
0
58.99
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,714.22
0
4,714.22
Earnings per share (EPS)
0.10
0
0.10
Diluted Earnings per share
0.10
0
0.10
Operating Profit Margin (Excl OI)
6.62%
0%
0.00
6.62%
Gross Profit Margin
10.32%
0%
0.00
10.32%
PAT Margin
8.17%
0%
0.00
8.17%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 70.11 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -8.23% vs -11.32% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -17.49% vs -9.88% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.90 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -6.65% vs -26.17% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -36.35% vs 20.55% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.64 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -55.08% vs -29.39% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -64.55% vs 13.24% in Sep 2024
Quarterly - Interest
Interest 0.30 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.62%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
